Earnings · China A-shares

Staidson (Beijing) Biopharmaceuticals Co. Ltd. Class A (300204) earnings

Staidson (Beijing) Biopharmaceuticals Co. Ltd. Class A published its Q3 report on 2026-10-29: net profit -70.97% year on year, -58.26% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -1.41% in the 3 trading days after the report.

Report
Q3 report
Published
2026-10-29
Period end
2026-09-30
Net profit YoY
-70.97%
Excl. one-offs YoY
-58.26%
Result
Bad / loss
Quality score
59
Quality
Questionable
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-1.47%—
3 days-1.41%—
7 days+3.42%—
14 days-6.24%—

Report history

Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 4 of 7 reports (average -0.83%).

ReportPublishedNet profitProfit YoYExcl. one-offs YoYRevenue YoYEPSROE3 days after30 days after30d vs index
2026 Q3 report2026-10-30-¥52.47M-70.97%-58.26%-18.47%-0.11-4.88%-1.41%——
2026 interim report2026-08-25-¥36.77M-49.25%-36.58%-26.03%-0.08-4.52%+4.19%-5.67%+0.36%
2026 Q1 report2026-04-28-¥8.43M-261.10%—-25.81%-0.02-1.03%+0.44%-25.92%-25.30%
2025 annual report2026-04-28-¥77.76M+46.31%+46.74%-32.20%-0.16-8.89%+0.44%-25.92%-25.30%
2025 Q3 report2025-10-29-¥30.69M-227.71%—-30.82%-0.06-3.41%+13.18%-16.61%-13.14%
2025 interim report2025-08-26-¥24.64M-619.70%—-31.14%-0.05-2.70%-14.79%-47.16%-48.84%
2025 Q1 report2025-04-25-¥2.34M+38.05%+23.93%-33.45%0.00-0.26%-9.05%+161.81%+158.56%
2024 annual report2025-03-25-¥144.84M+63.69%+62.19%-10.81%-0.30-15.04%+1.65%+51.65%+55.26%

The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.

Stock valuations: 300204

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.